Methotrexate treatment for advanced bowel cancer


Scientists at the Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research (ICR) in London tested a range of drugs on cells with the faulty MSH2 gene.


They found that a drug called methotrexate worked well in destroying these cells.


This study suggests that methotrexate could treat people, whose cancer is driven by the MSH2 genetic fault, potentially opening the door to a more targeted treatment


Source: Cancer Research U.K.